Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 7, 2010Critical CareOpen Access

Drotrecogin alfa (activated) may attenuate severe sepsis-associated encephalopathy in clinical septic shock

View Full Paper
Ask AI
Bookmark
Share

Authors

HSHerbert SpapenDNDuc Nam NguyenJTJoris Troubleyn

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Spapen et al. (2010) studied this question.

synapsesocial.com/papers/6a7b41c8dd2e05b79c3221bfhttps://doi.org/10.1186/cc8947
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Activated protein C therapy slows ALS-like disease in mice by transcriptionally inhibiting SOD1 in motor neurons and microglia cells2009 · 174 citations
  2. 2Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis2001 · 6,166 citations
  3. 3Anti-Inflammatory, Antithrombotic, and Neuroprotective Effects of Activated Protein C in a Murine Model of Focal Ischemic Stroke2001 · 197 citations
  4. 4The Spectrum of Septic Encephalopathy1996 · 435 citations
  5. 5Activated protein C and sepsis2006 · 21 citations